MDxHealth

About:

MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.

Website: http://mdxhealth.com

Twitter/X: MDxHealth

Top Investors: EASME - EU Executive Agency for SMEs, Idinvest Partners, Kreos Capital, MVM Life Science Partners, Innovatus Capital Partners

Description:

MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.

Total Funding Amount:

$169M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Irvine, California, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)mdxhealth.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-09-25

IPO Status:

Public

Industries:

© 2025 bioDAO.ai